[1] Rinella M E. Nonalcoholic fatty liver disease: a systematic review[J]. JAMA ,2015,313(22):2263-2273.
[2] Hardy T, Oakley F, Anstee Q M, et al. Nonalcoholic fatty liver disease: pathogenesis and disease spectrum[J]. Annu Rev Pathol, 2016, 11(1):451-496.
[3] Le M H, Yeo Y H, Zou B, et al. Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach[J]. Clin Mol Hepatol, 2022,28(4):841-850.
[4] Newton J L, Jones D E, Henderson E, et al. Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance[J]. Gut,2008,57(6):807-813.
[5] Younossi Z M , Stepanova M , Myers R P , et al. The potential role of fatigue in identifying patients with NASH and advanced fibrosis who experience disease progression[J]. Clin Gastroenterol Hepatol, 2023,21(4):970-977.
[6] Golubeva J A, Sheptulina A F, Yafarova A A, et al. Reduced quality of life in patients with non-alcoholic fatty liver disease may be associated with depression and fatigue[J]. Healthcare (Basel), 2022,10(9):1699.
[7] Deary V, Hagenaars S P, Harris S E, et al. Genetic contributions to self-reported tiredness[J]. Mol Psychiatry, 2017, 23(3):609-620.
[8] Aaronson L S, Teel C S, Cassmeyer V, et al. Defining and measuring fatigue[J]. Image J Nurs Sch,1999,31(1):45-50.
[9] Rui L. Energy metabolism in the liver[J]. Compr Physiol, 2014, 4(1):177-197.
[10] Ijaz S, Yang W, Winslet M C,et al. Impairment of hepatic microcirculation in fatty liver[J]. Microcirculation,2003,10(6):447-456.
[11] Younossi Z M, Wong V W, Anstee Q M, et al. Fatigue and pruritus in patients with advanced fibrosis due to nonalcoholic steatohepatitis: the impact on patient-reported outcomes[J]. Hepatol Commun,2020,4(11):1637-1650.
[12] Chalasani N, Younossi Z, Lavine J E, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases[J]. Hepatology,2018,67(1):328-357.
[13] Zhu B, Chen X, Park C G, et al. Fatigue and sleep quality predict eating behavior among people with type 2 diabetes[J]. Nurs Res, 2020,69(6):419-426.
[14] Glass O, Liu D, Bechard E, et al. Perceptions of exercise and its challenges in patients with nonalcoholic fatty liver disease: a survey-based study[J]. Hepatol Commun, 2022, 6(2):334-344.
[15] Yellen S B, Cella D F, Webster K, et al. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy(FACT) measurement system[J]. J Pain Symptom Manage,1997,13(2):63-74.
[16] 杨冉, 林琳, 季建敏,等. 中文版慢性病治疗功能评估-疲劳量表在ITP患者中的应用及疲劳影响因素分析[J]. 临床血液学杂志, 2019(2):213-216,218.
[17] 王思远,高敏,赵岳.中文版慢性病治疗功能评估-疲劳量表在维持性血液透析患者中的信效度评定[J].中华护理杂志,2014,49(5):613-617.
[18] Fisk J D, Ritvo P G, Ross L, et al. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis, 1994, 18(Suppl 1): S79-83.
[19] Wu C W, Liu Z D, Zhang Y B, et al. Validity and reliability of Chinese version of Fatigue mpact Scale in cerebral infarction patients[J]. Neural Regeneration Research, 2008, 3(2):5.
[20] Fisk J D, Doble S E. Construction and validation of a fatigue impact scale for daily administration (D-FIS)[J]. Qual Life Res, 2002,11(3):263-272.
[21] Larson R D. Psychometric properties of the modified fatigue impact scale[J]. Int J MS Care,2013,15(1):15-20.
[22] Michielsen H J, De Vries J, Van Heck G L. Psychometric qualities of a brief self-rated fatigue measure: the fatigue assessment scale[J]. J Psychosom Res, 2003,54(4):345-352.
[23] Hendriks C, Drent M, Elfferich M, et al. The fatigue assessment scale: quality and availability in sarcoidosis and other diseases[J]. Curr Opin Pulm Med,2018,24(5):495-503.
[24] Cumming T B, Mead G. Classifying post-stroke fatigue: Optimal cut-off on the fatigue assessment scale[J]. J Psychosom Res,2017,103:147-149.
[25] Bhandari K, Kapoor D. Fatigue in cirrhosis[J]. J Clin Exp Hepatol,2022,12(2): 617-624.
[26] Younossi Z M, Guyatt G, Kiwi M, et al. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease[J]. Gut, 1999, 45(2):295-300.
[27] 陈雨彤,张伟,谷云鹏,等.非酒精性脂肪性肝病生活质量量表的汉化及其信效度检验[J].中华肝脏病杂志,2022,30(9):981-985.
[28] Younossi Z M, Stepanova M, Henry L, et al. A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD[J]. Liver Int, 2017, 37(8): 1209-1218.
[29] Lee K A, Hicks G, Nino-Murcia G. Validity and reliability of a scale to assess fatigue[J]. Psychiatry Res,1991,36(3):291-298.
[30] 任似梦,吴晓月,周慧灵,等.癌因性疲乏患者报告结局评估工具研究进展[J].世界中医药,2021,16(13):1928-1931,1936.
[31] Newton J L, Pairman J, Wilton K, et al. Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease[J]. Clin Auton Res, 2009,19(6):319-326.
[32] Castellanos-Fernández M I, Borges-González S A, Stepanova M, et al. Health-related quality of life in Cuban patients with chronic liver disease: a real-world experience[J]. Ann Hepatol, 2021,22:100277.
[33] Francque S M, Marchesini G, Kautz A, et al. Non-alcoholic fatty liver disease: a patient guideline[J]. JHEP Rep,2021,3(5):100322.
[34] Sheptulina A F, Yafarova A A, Golubeva J A, et al. Clinically meaningful fatigue and depression are associated with sarcopenia in patients with non-alcoholic fatty liver disease[J]. J Pers Med, 2023, 13(6):932.
[35] Oh B, Choi W S, Park S B, et al. Efficacy and safety of ursodeoxycholic acid composite on fatigued patients with elevated liver function and/or fatty liver: a multi-centre, randomised, double-blinded, placebo-controlled trial[J]. Int J Clin Pract. 2016,70(4):302-311.
[36] 陈姗,罗莎,梁彩虹.中药联合穴位埋线治疗非酒精性脂肪性肝病50例[J].江西中医药,2015,46(6):34-35. |
